Catalyst Pharmaceuticals Announces Settlement of U.S. Patent Litigation and Resolution of Litigation Challenging Ruzurgi® Approval with Jacobus Pharmaceutical
As Part of the Settlement, Catalyst has Acquired Certain of Jacobus’ Intellectual Property Rights, Including…